Average body weight trends for the four groups during the post-challenge period. by Oumayma Arbani (21001472)

Subjects:

Microscopical lesions in trachea and lungs H&E staining on dpi 10. A) Moderate to severe subacute tracheitis (score 2) with epithelial hyperplasia (Asterisk) and mixed inflammatory... by Oumayma Arbani (21001472)

Subjects:

Trends of average respiratory symptom scores during the post-challenge period. by Oumayma Arbani (21001472)

Subjects:

Quantitative estimation of viral concentration from qRT-PCR data using a regression equation. by Oumayma Arbani (21001472)

Subjects:

Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

Tumor volume measurements. by Hedieh Zargaran (21410233)

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

Subjects:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient of all 17 dogs. by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf by Yi Li (1144)

“…</p>Conclusion<p>Prehospital TXA decreases early (24-h) mortality in trauma patients without a significant increase in the risk of VTE and other complications, and further studies are still needed to improve and optimize its management strategy.…”

S1 Dataset - by Junxia Zhou (14381598)

Subjects:

Fig 11 - by Junxia Zhou (14381598)

Subjects:

Orthogonal design and experimental results for MUCG mix proportions. by Junxia Zhou (14381598)

Subjects:

Slurry performance and compressive strength of MUCG and other grouting materials. by Junxia Zhou (14381598)

Subjects:

Mineral content of raw materials. by Junxia Zhou (14381598)

Subjects:

Normalization of MUCG properties of slurry and UCS values. by Junxia Zhou (14381598)

Subjects: